a common complication of prosthetic heart valves is thrombosis. although the incidence of prosthetic valve thrombosis (pvt) in the tricuspid position is high, there are not enough data on the management of it, in contrast to left-sided pvt. here, we describe three cases of tricuspid pvt with three different management approaches: thrombolytic therapy; close observation with oral anticoagulants;...

introduction: the precise time of using percutaneous coronary intervention (pci) after fibrinolytic therapy for maximum efficiency and minimum side effects is still undetermined. therefore, the present study was designed to compare the outcome of myocardial infarction (mi) patients who underwent surgical intervention (angiography and pci) within 48 hours of thrombolytic therapy or after that. m...

abstract sesbania grandiflora leaves are extensively used locally since ancient time as in traditional systems. base on mainly folkloric use, we investigated to know the potential of sesbania grandiflora leaves extracts through biological works in vivo and in vitro. the ethanolic extract of s. grandiflora leaves was partitioned into ethyl acetate soluble fraction (esf), petroleum ether soluble ...

Thrombolytics recanalize thrombotic occlusion associated with STsegment elevation myocardial infarction (STEMI) and restoration of coronary flow reduces infarct size and improves myocardial function and survival over the short-term and long-term. Thrombolytic therapy for acute myocardial infarction (AMI) was incorporated into the armamentarium of clinicians over 2 decades ago, and has evolved f...

There has been rapid proliferation of understanding and experience with thrombolytic therapy for acute myocardial infarction. Over the last few years, selective intracoronary infusion of lytic therapy has been replaced by intravenous administration because of the fundamental importance of time to reperfusion. Newer thrombolytic agents, such as tissue plasminogen activator (t-PA) and acylated st...

Pulmonary embolism (PE) is a common disorder that is accompanied by significant morbidity and mortality. Although anticoagulation is the standard treatment for PE, thrombolytic therapy, with its ability to produce rapid clot lysis, has long been considered an attractive alternative. Although many studies have been performed over the past three decades, however, the indications for the use of th...

or benefit from this approach. We searched for studies including two or more patients treated with throm¬ bolytic agents. Ten studies were reviewed. We de¬ scribe and include two patients with valve thrombosis treated at our institution. A total of 182 episodes of prosthetic valve thrombosis in 162 patients were ex¬ amined. Clinical success was achieved in 72.0% of cases and there was a mortali...

BACKGROUND: Thrombolytic treatment is the main of acute ischemic stroke. Thailand started thrombolytic in 2008 only at university hospitals Bangkok and gradually increased services large provincial until widespread 2014. However, no studies regard stroke management Thailand.
 AIM: This study aims to present data: incidence, rate treatment, mortality for 13 years
 METHODS: A from Natio...

We have read with interest the review article by Pulido et al. Early risk stratification is the cornerstone for success and effective therapy in acute pulmonary embolism (PE). Submassive (intermediate-risk) PE (20--25% of all PE events) represents a subgroup of patients with significant in-hospital mortality between 6 and 8%. Submassive PE has been defined as patients presenting with preserved ...

T he open artery hypothesis suggests that establishing reperfusion as soon as possible after the onset of symptoms of acute myocardial infarction should be a priority; this has been highlighted as an important objective in the National Service Framework document in the UK. Currently, patients with acute myocardial infarction are treated with thrombolytic therapy or by percutaneous coronary inte...